AVEO Pharmaceuticals Inc (AVEO)

4.84 +0.05  +1.04% NASDAQ Jul 7, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 Earnings AVEO Pharmaceuticals Inc Second Quarter Earnings Results in 2020
06/10/2020 10:00 EDT Misc AVEO Pharmaceuticals Inc Annual General Meeting for 2019
04/30/2020 Earnings AVEO Pharmaceuticals Inc First Quarter Earnings Results for 2020
03/16/2020 Earnings AVEO Pharmaceuticals Inc Fourth Quarter Earnings Results for 2019
03/16/2020 Misc AVEO Pharmaceuticals Inc Annual Report for 2019
02/20/2020 Splits Ratio: 1:10
11/12/2019 Earnings AVEO Pharmaceuticals Inc Third Quarter Earnings Results for 2019
08/08/2019 Earnings AVEO Pharmaceuticals Inc Second Quarter Earnings Results in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.aveooncology.com
  • Investor Relations URL: http://investor.aveooncology.com/phoenix.zhtml?c=219651&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: Apr. 30, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: AVEO Pharmaceuticals Inc is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need. The Company's aim is to retain North American rights to its oncology portfolio while securing partners in development and commercialization outside of North America. It is seeking to develop and commercialize its lead candidate tivozanib in North America as a treatment for advanced or metastatic renal cell carcinoma (RCC). It has outlicensed tivozanib (FOTIVDA) for oncology in Europe and other territories outside North America. Tivozanib is approved in the European Union as well as Norway and Iceland for the first-line treatment of adult patients with RCC.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.